688321 微芯生物
按盤價 
31.780 +3.550 (+12.575%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.343 | 3.178 | -6.963 | 5.509 | 1.192 |
| 總資產報酬率 ROA (%) | 0.687 | 1.477 | -3.550 | 2.913 | 0.730 |
| 投入資產回報率 ROIC (%) | 0.766 | 1.652 | -3.909 | 3.336 | 0.856 | 邊際利潤分析 |
| 銷售毛利率 (%) | 85.798 | 87.118 | 86.706 | 89.122 | 94.341 |
| 營業利潤率 (%) | 11.242 | 5.506 | -27.130 | 18.535 | 3.014 |
| 息稅前利潤/營業總收入 (%) | 13.979 | 7.863 | -12.527 | 21.588 | 3.418 |
| 淨利潤/營業總收入 (%) | 10.999 | 5.600 | -17.413 | 9.392 | 2.418 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 113.380 | 127.942 | 80.209 | -201.582 | 22.558 |
| 價值變動淨收益/利潤總額(%) | -17.242 | -49.623 | 22.335 | 290.695 | 15.832 |
| 營業外收支淨額/利潤總額(%) | -0.852 | -0.119 | -84.572 | -0.055 | -5.388 | 償債能力分析 |
| 流動比率 (X) | 2.564 | 1.399 | 2.401 | 2.892 | 2.191 |
| 速動比率 (X) | 2.492 | 1.330 | 2.310 | 2.771 | 2.138 |
| 資產負債率 (%) | 43.592 | 55.463 | 51.364 | 46.620 | 45.587 |
| 帶息債務/全部投入資本 (%) | 34.551 | 44.872 | 42.101 | 34.167 | 29.849 |
| 股東權益/帶息債務 (%) | 179.447 | 112.777 | 127.070 | 172.198 | 209.878 |
| 股東權益/負債合計 (%) | 129.401 | 80.301 | 94.688 | 114.500 | 114.800 |
| 利息保障倍數 (X) | 4.936 | 3.327 | -5.769 | 7.049 | 6.129 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 101.872 | 88.409 | 97.360 | 120.073 | 89.983 |
| 存貨周轉天數 (天) | 143.138 | 151.278 | 181.037 | 238.879 | 263.140 |
| 備註： | 即時報價更新時間為 15/07/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
